Publication | Closed Access

Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis

InflammationRheumatologyAnti-inflammatoryMedicineRheumatic DiseasesJak2/stat3 Transcription FactorsImmune RegulationImmunologyChronic InflammationOsteoarthritisInflammatory Rheumatic DiseaseInnate ImmunityPharmacologyInflammatory DiseaseNf-κb/i κBInflammatory ArthritisInflammation Mediators